NCT04782843 (REPROHEP) is a clinical trial of HEP score assessement in Heparin-induced Thrombocytopenia, sponsored by Centre Hospitalier Universitaire de Besancon.

Who is sponsoring NCT04782843?

NCT04782843 is sponsored by Centre Hospitalier Universitaire de Besancon.

What drugs are being tested in NCT04782843?

Interventions in NCT04782843: HEP score assessement.

What condition does NCT04782843 study?

NCT04782843 studies Heparin-induced Thrombocytopenia.

Is NCT04782843 still recruiting?

NCT04782843 is currently status unknown. Last updated 4 March 2021.

Last reviewed 2021-03-04 · How we verify

NCT04782843: REPROHEP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care.

Status unknown Last updated 4 March 2021

What this trial tests

trial testing HEP score assessement in Heparin-induced Thrombocytopenia in 124 participants. Status unknown.

Timeline

1 March 2021

Primary endpoint
1 May 2021

1 May 2021

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Besancon
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	124
Start date	1 March 2021
Primary completion	1 May 2021
Estimated completion	1 May 2021

Drugs / interventions tested

HEP score assessement

Conditions studied

Heparin-induced Thrombocytopenia — all drugs for Heparin-induced Thrombocytopenia →

Sponsor

Centre Hospitalier Universitaire de Besancon

Who can join

18 and older, any sex, with Heparin-induced Thrombocytopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this work is to assess the intraoperator reproducibility in the calculation of the HEP score in a population of intensive care patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Centre Hospitalier Universitaire de Besancon trials

Trials by the same sponsor.

NCT07492199 — High Depth Exome Sequencing on DNA From a Salivary Sample by Mouth Smear. · not yet recruiting
NCT07438015 — VEXUS-REA : Evaluation of Ultrasound Parameters of Venous Congestion in Patients in a Medical Intensive Care Unit · NA · not yet recruiting
NCT06796114 — Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Du · NA · recruiting
NCT06864065 — Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder · NA · recruiting
NCT07067762 — Botulinum Toxin Injections Into the Salivary Glands of Cerebrospinal Children With Chronic Sialorrhea · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04782843 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Besancon
Last refreshed: 4 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04782843.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing